| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69315-236-01 | 69315-236 | HUMAN PRESCRIPTION DRUG | MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | CAPSULE | ORAL | 20230727 | N/A | ANDA | ANDA215876 | Leading Pharma, LLC | MEXILETINE HYDROCHLORIDE | 150 mg/1 | 100 CAPSULE in 1 BOTTLE (69315-236-01) |
| 69315-237-01 | 69315-237 | HUMAN PRESCRIPTION DRUG | MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | CAPSULE | ORAL | 20230727 | N/A | ANDA | ANDA215876 | Leading Pharma, LLC | MEXILETINE HYDROCHLORIDE | 200 mg/1 | 100 CAPSULE in 1 BOTTLE (69315-237-01) |
| 69315-238-01 | 69315-238 | HUMAN PRESCRIPTION DRUG | MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | CAPSULE | ORAL | 20230727 | N/A | ANDA | ANDA215876 | Leading Pharma, LLC | MEXILETINE HYDROCHLORIDE | 250 mg/1 | 100 CAPSULE in 1 BOTTLE (69315-238-01) |